Effect of paiteling on human papillomavirus infection of the cervix

Tao,Pingping; Zheng,Weiping; Meng,Xiaohua; Chen,Junxia; Sun,Aijing; Shou,Qinghe; Wang,Yungen; Yang,Binlie

doi:10.3892/mco.2017.1454

Effect of paiteling on human papillomavirus infection of the cervix

Authors:
- Pingping Tao
- Weiping Zheng
- Xiaohua Meng
- Junxia Chen
- Aijing Sun
- Qinghe Shou
- Yungen Wang
- Binlie Yang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Shanghai Pudong New Area People's Hospital, Shanghai 201299, P.R. China, Department of Gynaecology, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, P.R. China, Department of Pathology, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China
Published online on: October 17, 2017 https://doi.org/10.3892/mco.2017.1454
Pages: 957-964
Copyright: © Tao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of the traditional Chinese medicine paiteling on the outcome of high‑risk human papillomavirus (HR‑HPV) infection of the cervix. A total of 321 patients were enrolled in this study and HPV subtypes were determined by the Hybribio HPV genotyping system. The patients were divided into the loop electrosurgical excision procedure (LEEP; n=82) and non‑LEEP (n=239) groups, according to the cervical intraepithelial neoplasia classification. These two groups were further subdivided into the drug (paiteling) and control subgroups. Thin‑prep cytology and HR‑HPV tests were performed every 3 months for 1 year. In the non‑LEEP group, the negative conversion rate of HR‑HPV and the regression rate of the cervical lesions in drug subgroup were significantly higher compared with those in the control subgroup. In the LEEP group, the seroconversion rate of the drug subgroup, but not the regression rate of the lesions, was significantly higher compared with that in the control subgroup. The seroconversion rate of HPV16‑infected patients at 12 months was 85.7%, whereas it reached 100% in all other HPV subtypes. Therefore, paiteling may accelerate the clearance of HPV infection and the regression of cervical lesions.

View Figures

View References

1	Ogunwale AN, Coleman MA, Sangi-Haghpeykar H, Valverde I, Montealegre J, Jibaja-Weiss M and Anderson ML: Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS. AIDS Care. 28:1–4. 2016. View Article : Google Scholar
2	Qiu AD, Wu EQ, Yu XH, Jiang CL, Jin YH, Wu YG, Chen Y, Chen Y, Shan YM, Zhang GN, et al: HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol. 104:77–85. 2007. View Article : Google Scholar : PubMed/NCBI
3	Ahmed HG, Bensumaidea SH and Ashankyty IM: Frequency of human papilloma virus (HPV) subtypes 31,33,35,39 and 45 among yemeni women with cervical cancer. Infect Agent Cancer. 10:292015. View Article : Google Scholar : PubMed/NCBI
4	Ingles DJ, Pierce Campbell CM, Messina JA, Stoler MH, Lin HY, Fulp WJ, Abrahamsen M, Sirak BA, O'Keefe MT, Papenfuss M, et al: Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV infection in men (HIM) study. J Infect Dis. 211:1060–1067. 2015. View Article : Google Scholar : PubMed/NCBI
5	Yuan Q, Han J, Cong W, Ge Y, Ma D, Dai Z, Li Y and Bi X: Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity. Int J Nanomedicine. 9:4829–4846. 2014.PubMed/NCBI
6	Parris GE: Hypothesis links emergence of chloroquine-resistant malaria and other intracellular pathogens and suggests a new strategy for treatment of diseases caused by intracellular parasites. Med Hypotheses. 62:354–357. 2004. View Article : Google Scholar : PubMed/NCBI
7	Kostova P and Zlatkov V: The Bethesda system: New revision of the terminology from 2001 year. Akush Ginekol (Sofiia). 43:52–55. 2004.(In Bulgarian). PubMed/NCBI
8	Bansal N, Wright JD, Cohen CJ and Herzog TJ: Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Res. 28:1763–1766. 2008.PubMed/NCBI
9	Kim JW, Song SH, Jin CH, Lee JK, Lee NW and Lee KW: Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res. 40:486–496. 2012. View Article : Google Scholar : PubMed/NCBI
10	Bae J, Seo SS, Park YS, Dong SM, Kang S, Myung SK and Park SY: Natural history of persistent high-risk human papillomavirus infections in Korean women. Gynecol Oncol. 115:75–80. 2009. View Article : Google Scholar : PubMed/NCBI
11	Sycuro LK, Xi LF, Hughes JP, Feng Q, Winer RL, Lee SK, O'Reilly S, Kiviat NB and Koutsky LA: Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis. 198:971–978. 2008. View Article : Google Scholar : PubMed/NCBI
12	Ye J, Cheng X, Chen X, Ye F, Lu W and Xie X: Short-term type-specific HPV persistence and its predictors in an asymptomatic general female population in Zhejiang, China. Int J Gynaecol Obstet. 110:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
13	Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, et al: Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis. 36:305–311. 2009. View Article : Google Scholar : PubMed/NCBI
14	Munoz N, Hernandez-Suarez G, Mendez F, Molano M, Posso H, Moreno V, Murillo R, Ronderos M, Meijer C and Muñoz A: Instituto Nacional de Cancerología HPV Study Group: Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer. 100:1184–1190. 2009. View Article : Google Scholar : PubMed/NCBI
15	Guo YL, You K, Qiao J, Zhao YM, Liu CR and Geng L: Natural history of infections with high-risk HPV in Chinese women with abnormal cervical cytology findings at baseline. Int J Gynaecol Obstet. 110:137–140. 2010. View Article : Google Scholar : PubMed/NCBI
16	Castle PE, Walker JL, Schiffman M and Wheeler CM: Hormonal contraceptive use, pregnancy and parity and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer. 117:1007–1012. 2005. View Article : Google Scholar : PubMed/NCBI
17	Zheng X: Chinese medicine Paiteling treatment of condyloma acuminatum. The curative effect of 392 cases. China science. 15:282006.
18	Chen Rui ZJ and Liaoqin Ping: The clinical effects of paiteling on Cervical intraepithelial neoplasia grade 1 and 2. Chin J Pract Gynecol Obestet. 3:2011.
19	Tang Huagui XH, Wanyu, Xie Yane and Liu Xuefeng: Ou 2007 The Significance of Prognosis in different age groups eliminated CIN after Leep treatment by detection of HPV. J Hunan Norm Univ (Medical Sciences). 2007.
20	Li Rui-zhen LW, Changhuai, Zhang Zhihong Liu Yanqiu, Zhou Leiming and Weng Ruifang: Wu HPV clearance related factors after cervical intraepithelial neoplasia surgery. Chin J Matern Child Health Res. 2009:42009.
21	Alonso I, Torne A, Puig-Tintore LM, Esteve R, Quinto L, Campo E, Pahisa J and Ordi J: Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3. Gynecol Oncol. 103:631–636. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kim YT, Lee JM, Hur SY, Cho CH, Kim YT, Kim SC and Kang SB: Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer. 126:1903–1909. 2010.PubMed/NCBI
23	Yuquan ZMMXZ: Recent residual or recrudescent development of CIN after surgical cone. Chin J Clin Oncol. 34:32007.
24	Nagai Y, Maehama T, Asato T and Kanazawa K: Persistence of human papillomavirus infection after therapeutic conization for CIN 3: Is it an alarm for disease recurrence? Gynecol Oncol. 79:294–299. 2000. View Article : Google Scholar : PubMed/NCBI
25	Guo-Qin H: Clinical observation of paiteling on treatment of cervicitis combined with high-risk HPV infection. Chin J Woman Child Health Res. 23:32012.
26	Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C and Smith JS: Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis. Int J Cancer. 133:1271–1285. 2013. View Article : Google Scholar : PubMed/NCBI
27	Dong H, Liu Y, Tang Y and Liang F: Research on the circumstance of human papillomavirus gene subtypes changing into negativity. J Mol Diagn Therapy. 4:32012.(In Chinese).